perhexiline and fendiline

perhexiline has been researched along with fendiline in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (60.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Fossati, C; Guistiniani, S	1
Becker, HJ; Dowinsky, S; Hopf, R; Kaltenbach, M; Kober, G	1
Hochrein, H; Lehmann, HU	1
Ishiguro, N; Ito, M; Katagiri, T; Kawai, T; Kitoh, H; Masuda, A; Matsushita, M; Ohno, K; Yamamoto, R	1

Reviews

3 review(s) available for perhexiline and fendiline

Article	Year
[Side-effects of calcium antagonists]. La Clinica terapeutica, 1984, Jun-30, Volume: 109, Issue:6 Topics: Calcium Channel Blockers; Cardiovascular Diseases; Drug Hypersensitivity; Drug Interactions; Fendiline; Gastrointestinal Diseases; Humans; Lidoflazine; Nervous System Diseases; Nifedipine; Perhexiline; Prenylamine; Verapamil	1984
[Treatment of angina pectoris with calcium antagonists]. Herz, 1982, Volume: 7, Issue:4 Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Diltiazem; Drug Therapy, Combination; Exercise Test; Fendiline; Humans; Nicardipine; Nifedipine; Perhexiline; Prenylamine; Propafenone; Propiophenones; Verapamil	1982
[Indications for use of calcium antagonists]. Medizinische Klinik, 1980, Apr-11, Volume: 75, Issue:8 Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Cardiotonic Agents; Coronary Disease; Female; Fendiline; Humans; Hyperinsulinism; Hypertension; Nifedipine; Obstetric Labor, Premature; Paraganglioma; Perhexiline; Pregnancy; Prenylamine; Vasodilator Agents; Verapamil	1980

Other Studies

2 other study(ies) available for perhexiline and fendiline

Article	Year
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice. Journal of bone and mineral metabolism, 2013, Volume: 31, Issue:1 Topics: Activin Receptors, Type I; Animals; Bone Morphogenetic Protein 2; Calcium Channel Blockers; Cell Line; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fendiline; Inhibitor of Differentiation Protein 1; Mice; Mice, Mutant Strains; Muscle Cells; Mutation; Myositis Ossificans; Ossification, Heterotopic; Osteoblasts; Perhexiline; Promoter Regions, Genetic; Smad Proteins	2013

Article

Year

Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.

Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2

Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase

2008

Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice.

Journal of bone and mineral metabolism, 2013, Volume: 31, Issue:1

Topics: Activin Receptors, Type I; Animals; Bone Morphogenetic Protein 2; Calcium Channel Blockers; Cell Line; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fendiline; Inhibitor of Differentiation Protein 1; Mice; Mice, Mutant Strains; Muscle Cells; Mutation; Myositis Ossificans; Ossification, Heterotopic; Osteoblasts; Perhexiline; Promoter Regions, Genetic; Smad Proteins

2013